JPS5035315A - - Google Patents

Info

Publication number
JPS5035315A
JPS5035315A JP8543973A JP8543973A JPS5035315A JP S5035315 A JPS5035315 A JP S5035315A JP 8543973 A JP8543973 A JP 8543973A JP 8543973 A JP8543973 A JP 8543973A JP S5035315 A JPS5035315 A JP S5035315A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8543973A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP8543973A priority Critical patent/JPS5035315A/ja
Publication of JPS5035315A publication Critical patent/JPS5035315A/ja
Pending legal-status Critical Current

Links

Landscapes

  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP8543973A 1973-07-31 1973-07-31 Pending JPS5035315A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8543973A JPS5035315A (ja) 1973-07-31 1973-07-31

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8543973A JPS5035315A (ja) 1973-07-31 1973-07-31

Publications (1)

Publication Number Publication Date
JPS5035315A true JPS5035315A (ja) 1975-04-04

Family

ID=13858878

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8543973A Pending JPS5035315A (ja) 1973-07-31 1973-07-31

Country Status (1)

Country Link
JP (1) JPS5035315A (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998047518A1 (de) * 1997-04-17 1998-10-29 Europäisches Laboratorium für Molekularbiologie (EMBL) Verwendung von cholesterinsenkenden mitteln zur beeinflussing von signaltransduktionsvorgängen an der zellmembran, in die prophylaxe oder behandlung von prion-assorzierte- oder alzheimerische krankheit

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998047518A1 (de) * 1997-04-17 1998-10-29 Europäisches Laboratorium für Molekularbiologie (EMBL) Verwendung von cholesterinsenkenden mitteln zur beeinflussing von signaltransduktionsvorgängen an der zellmembran, in die prophylaxe oder behandlung von prion-assorzierte- oder alzheimerische krankheit

Similar Documents

Publication Publication Date Title
AU476761B2 (ja)
AU465372B2 (ja)
AU474593B2 (ja)
AU474511B2 (ja)
AU474838B2 (ja)
AU465453B2 (ja)
AU471343B2 (ja)
AU465434B2 (ja)
AU450229B2 (ja)
AU476714B2 (ja)
AU472848B2 (ja)
AU476696B2 (ja)
AU466283B2 (ja)
AU477823B2 (ja)
JPS5035315A (ja)
AU447540B2 (ja)
AU471461B2 (ja)
AR197627A1 (ja)
AR210729A1 (ja)
AU461342B2 (ja)
AU477824B2 (ja)
AU476873B1 (ja)
AR196382A1 (ja)
AU1891376A (ja)
AR196212Q (ja)